Aspen Expands in China as African Drugmaker Targets Growth

  • South African company adding 350 China sales representatives
  • Low-cost drugs in high demand in world’s most populous country

Aspen Pharmacare Holdings Ltd. plans to increase its Chinese presence as Africa’s biggest maker of generic drugs ramps up distribution of its low-cost pharmaceuticals in the world’s most-populous country.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.